295 related articles for article (PubMed ID: 37954456)
1. Platelet-Based Nanoparticles with Stimuli-Responsive for Anti-Tumor Therapy.
Yang L; Zhang K; Zheng D; Bai Y; Yue D; Wu L; Ling H; Ni S; Zou H; Ye B; Liu C; Deng Y; Liu Q; Li Y; Wang D
Int J Nanomedicine; 2023; 18():6293-6309. PubMed ID: 37954456
[TBL] [Abstract][Full Text] [Related]
2. The Smart Dual-Stimuli Responsive Nanoparticles for Controlled Anti-Tumor Drug Release and Cancer Therapy.
Wu F; Qiu F; Wai-Keong SA; Diao Y
Anticancer Agents Med Chem; 2021; 21(10):1202-1215. PubMed ID: 32972353
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated-platelet-inspired nanomedicines for cancer therapy.
Geranpayehvaghei M; Dabirmanesh B; Khaledi M; Atabakhshi-Kashi M; Gao C; Taleb M; Zhang Y; Khajeh K; Nie G
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1702. PubMed ID: 33538125
[TBL] [Abstract][Full Text] [Related]
4. Platelets and their biomimetics for regenerative medicine and cancer therapies.
Li Z; Hu S; Cheng K
J Mater Chem B; 2018 Dec; 6(45):7354-7365. PubMed ID: 31372220
[TBL] [Abstract][Full Text] [Related]
5. Platelet mimicry: The emperor's new clothes?
Moghimi SM; Hunter AC; Peer D
Nanomedicine; 2016 Jan; 12(1):245-8. PubMed ID: 26409192
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticle biointerfacing by platelet membrane cloaking.
Hu CM; Fang RH; Wang KC; Luk BT; Thamphiwatana S; Dehaini D; Nguyen P; Angsantikul P; Wen CH; Kroll AV; Carpenter C; Ramesh M; Qu V; Patel SH; Zhu J; Shi W; Hofman FM; Chen TC; Gao W; Zhang K; Chien S; Zhang L
Nature; 2015 Oct; 526(7571):118-21. PubMed ID: 26374997
[TBL] [Abstract][Full Text] [Related]
7. Platelet Membrane-Coated and VAR2CSA Malaria Protein-Functionalized Nanoparticles for Targeted Treatment of Primary and Metastatic Cancer.
Zhou M; Lai W; Li G; Wang F; Liu W; Liao J; Yang H; Liu Y; Zhang Q; Tang Q; Hu C; Huang J; Zhang R
ACS Appl Mater Interfaces; 2021 Jun; 13(22):25635-25648. PubMed ID: 34038097
[TBL] [Abstract][Full Text] [Related]
8. Self-promoted Albumin-Based Nanoparticles for Combination Therapy against Metastatic Breast Cancer via a Hyperthermia-Induced "Platelet Bridge".
Zhao W; Li T; Long Y; Guo R; Sheng Q; Lu Z; Li M; Li J; Zang S; Zhang Z; He Q
ACS Appl Mater Interfaces; 2021 Jun; 13(22):25701-25714. PubMed ID: 34041901
[TBL] [Abstract][Full Text] [Related]
9. 'Adhesion and release' nanoparticle-mediated efficient inhibition of platelet activation disrupts endothelial barriers for enhanced drug delivery in tumors.
Cao J; Yang P; Wang P; Xu S; Cheng Y; Qian K; Xu M; Sheng D; Li Y; Wei Y; Zhang Q
Biomaterials; 2021 Feb; 269():120620. PubMed ID: 33421709
[TBL] [Abstract][Full Text] [Related]
10. A review of nanoparticle drug delivery systems responsive to endogenous breast cancer microenvironment.
Zou T; Lu W; Mezhuev Y; Lan M; Li L; Liu F; Cai T; Wu X; Cai Y
Eur J Pharm Biopharm; 2021 Sep; 166():30-43. PubMed ID: 34098073
[TBL] [Abstract][Full Text] [Related]
11. Perfluorocarbon Nanoparticles Mediated Platelet Blocking Disrupt Vascular Barriers to Improve the Efficacy of Oxygen-Sensitive Antitumor Drugs.
Zhou Z; Zhang B; Wang S; Zai W; Yuan A; Hu Y; Wu J
Small; 2018 Nov; 14(45):e1801694. PubMed ID: 30307696
[TBL] [Abstract][Full Text] [Related]
12. Platelet membrane-based and tumor-associated platelettargeted drug delivery systems for cancer therapy.
Zhang Y; Liu G; Wei J; Nie G
Front Med; 2018 Dec; 12(6):667-677. PubMed ID: 29619757
[TBL] [Abstract][Full Text] [Related]
13. Platelets for cancer treatment and drug delivery.
Xiao G; Zhang Z; Chen Q; Wu T; Shi W; Gan L; Liu X; Huang Y; Lv M; Zhao Y; Wu P; Zhong L; He J
Clin Transl Oncol; 2022 Jul; 24(7):1231-1237. PubMed ID: 35218523
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of intrinsic coagulation improves safety and tumor-targeted drug delivery of cationic solid lipid nanoparticles.
Wu X; Chen H; Wu C; Wang J; Zhang S; Gao J; Wang H; Sun T; Yang YG
Biomaterials; 2018 Feb; 156():77-87. PubMed ID: 29190500
[TBL] [Abstract][Full Text] [Related]
15. Advances in Targeting Drug Biological Carriers for Enhancing Tumor Therapy Efficacy.
Xia D; Li J; Feng L; Gao Z; Liu J; Wang X; Hu Y
Macromol Biosci; 2023 Dec; 23(12):e2300178. PubMed ID: 37466216
[TBL] [Abstract][Full Text] [Related]
16. Application and design of esterase-responsive nanoparticles for cancer therapy.
Dong H; Pang L; Cong H; Shen Y; Yu B
Drug Deliv; 2019 Dec; 26(1):416-432. PubMed ID: 30929527
[TBL] [Abstract][Full Text] [Related]
17. Platelet extracellular vesicles are efficient delivery vehicles of doxorubicin, an anti-cancer drug: preparation and in vitro characterization.
Wu YW; Lee DY; Lu YL; Delila L; Nebie O; Barro L; Changou CA; Lu LS; Goubran H; Burnouf T
Platelets; 2023 Dec; 34(1):2237134. PubMed ID: 37580876
[TBL] [Abstract][Full Text] [Related]
18. Platelet-membrane-biomimetic nanoparticles for targeted antitumor drug delivery.
Wang H; Wu J; Williams GR; Fan Q; Niu S; Wu J; Xie X; Zhu LM
J Nanobiotechnology; 2019 May; 17(1):60. PubMed ID: 31084622
[TBL] [Abstract][Full Text] [Related]
19. Targeted Inhibition of Tumor Inflammation and Tumor-Platelet Crosstalk by Nanoparticle-Mediated Drug Delivery Mitigates Cancer Metastasis.
Li S; Li L; Lin X; Chen C; Luo C; Huang Y
ACS Nano; 2022 Jan; 16(1):50-67. PubMed ID: 34873906
[TBL] [Abstract][Full Text] [Related]
20. Platelet membrane camouflaged nanoparticles: Biomimetic architecture for targeted therapy.
Kunde SS; Wairkar S
Int J Pharm; 2021 Apr; 598():120395. PubMed ID: 33639226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
